-ESPN Report
FibroGen Staring At Multi-Year Lows Following Adverse Roxadustat AdCom Verdict; How Hard Will The Stock Likely Fall?
FibroGen, Inc.’s (NASDAQ: FGEN) shares are sinking to their lowest level since late June 2016.
Related Posts
Lucy Scientific Discovery Plans To Manufacture Cocaine And Heroin To Supply Harm Reduction Programs Globally
Lucy Scientific Discovery Inc. (NASDAQ: LSDI) an early-stage psychedelics manufacturing company, has filed an amendment to its current Dealer’s License with Health Canada to add cocaine and heroin, among others to the list of approved substances t
ApeCoin Gets More Use Cases: Bored Ape & Mutant Ape Merch Only Sold For APE, Sportsbook Adds ApeCoin
Live for less than two weeks, ApeCoin is already seeing several use cases and is available to buy and sell across major cryptocurrency platforms. Here’s the latest on ApeCoin (CRYPTO:APE), a cryptocurrency that was launched by ApeDAO.